HIMS Long Call Strategy
HIMS (Hims & Hers Health, Inc.), in the Healthcare sector, (Medical - Equipment & Services industry), listed on NYSE.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes.
HIMS (Hims & Hers Health, Inc.) trades in the Healthcare sector, specifically Medical - Equipment & Services, with a market capitalization of approximately $7.57B, a beta of 2.40 versus the broader market, a 52-week range of 13.74-70.43, average daily share volume of 25.6M, a public-listing history dating back to 2019, approximately 2K full-time employees. These structural characteristics shape how HIMS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.40 indicates HIMS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on HIMS?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current HIMS snapshot
As of June 30, 2026, spot at $34.24, ATM IV 106.19%, IV rank 67.91%, expected move 30.44%. The long call on HIMS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.
Why this long call structure on HIMS specifically: HIMS IV at 106.19% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 30.44% (roughly $10.42 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HIMS expiries trade a higher absolute premium for lower per-day decay. Position sizing on HIMS should anchor to the underlying notional of $34.24 per share and to the trader's directional view on HIMS stock.
HIMS long call setup
The HIMS long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HIMS near $34.24, the first option leg uses a $33.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HIMS chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HIMS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $33.50 | $4.50 |
HIMS long call risk and reward
- Net Premium / Debit
- -$450.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$450.00
- Breakeven(s)
- $38.00
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
HIMS long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on HIMS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$450.00 |
| $7.58 | -77.9% | -$450.00 |
| $15.15 | -55.8% | -$450.00 |
| $22.72 | -33.6% | -$450.00 |
| $30.29 | -11.5% | -$450.00 |
| $37.86 | +10.6% | -$14.23 |
| $45.43 | +32.7% | +$742.73 |
| $53.00 | +54.8% | +$1,499.68 |
| $60.57 | +76.9% | +$2,256.64 |
| $68.14 | +99.0% | +$3,013.59 |
When traders use long call on HIMS
Long calls on HIMS express a bullish thesis with defined risk; traders use them ahead of HIMS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
HIMS thesis for this long call
The market-implied 1-standard-deviation range for HIMS extends from approximately $23.82 on the downside to $44.66 on the upside. A HIMS long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current HIMS IV rank near 67.91% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on HIMS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, HIMS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HIMS-specific events.
HIMS long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HIMS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HIMS alongside the broader basket even when HIMS-specific fundamentals are unchanged. Long-premium structures like a long call on HIMS are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current HIMS chain quotes before placing a trade.
Frequently asked questions
- What is a long call on HIMS?
- A long call on HIMS is the long call strategy applied to HIMS (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With HIMS stock trading near $34.24, the strikes shown on this page are snapped to the nearest listed HIMS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are HIMS long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the HIMS long call priced from the end-of-day chain at a 30-day expiry (ATM IV 106.19%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$450.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a HIMS long call?
- The breakeven for the HIMS long call priced on this page is roughly $38.00 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HIMS market-implied 1-standard-deviation expected move is approximately 30.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on HIMS?
- Long calls on HIMS express a bullish thesis with defined risk; traders use them ahead of HIMS catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current HIMS implied volatility affect this long call?
- HIMS ATM IV is at 106.19% with IV rank near 67.91%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.